Assessment of the effectiveness and satisfaction of platelet-rich plasma compared with hyaluronic acid in knee osteoarthritis at minimum 7-year follow-up: A post hoc analysis of a randomized controlled trial
Background: Knee osteoarthritis (KOA) can be effectively treated conservatively using platelet-rich plasma (PRP) injections into the affected joints. While the short-term therapeutic clinical benefits were well documented, the mid-term results remain undetermined. To clarify its efficacy, the mid-te...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2022-11-01
|
| Series: | Frontiers in Bioengineering and Biotechnology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fbioe.2022.1062371/full |
| _version_ | 1811186632201601024 |
|---|---|
| author | Zhengming Wang Zhengming Wang Rui Wang Sicheng Xiang Yong Gu Ting Xu Hengkai Jin Xinbo Gu Peijian Tong Hongsheng Zhan Hongsheng Zhan Shuaijie Lv |
| author_facet | Zhengming Wang Zhengming Wang Rui Wang Sicheng Xiang Yong Gu Ting Xu Hengkai Jin Xinbo Gu Peijian Tong Hongsheng Zhan Hongsheng Zhan Shuaijie Lv |
| author_sort | Zhengming Wang |
| collection | DOAJ |
| description | Background: Knee osteoarthritis (KOA) can be effectively treated conservatively using platelet-rich plasma (PRP) injections into the affected joints. While the short-term therapeutic clinical benefits were well documented, the mid-term results remain undetermined. To clarify its efficacy, the mid-term clinical outcomes of intra-articular injections of either PRP or hyaluronic acid (HA) in KOA were compared.Methods: One hundred patients who complied with the inclusion criteria were randomized to undergo once a week 3 weeks, intra-articular injections of either PRP or HA. Patients were evaluated before the injection, at 3, 6, and a mean of 78.9 months of follow-up. Eighty-five patients reached the final evaluation. Data on survival, re-intervention, pain, function, imaging, and satisfaction were collected and analyzed.Results: With surgery for any reason as the endpoint, the cumulative survival rate of the PRP group was 90%, while that of the HA group was 74%. There was a significant difference between the two groups in the total re-intervention rate (56.7% vs 16.2%, p < 0.05). The comparative analyses showed significant intergroup differences in the visual analog scale (VAS) and the Western Ontario and McMaster Universities Arthritis Index (WOMAC) (p < 0.01, p < 0.05, respectively) at the final follow-up. And base on the regression analyses, the type of treatment, age, and Kellgren-Lawrence (K-L) grade served as statistically an independent determinants of VAS (p < 0.001, p = 0.034, p < 0.001, respectively). Likewise, those variables independently determined WOMAC in our study. However, no difference was observed in the imaging evaluation, containing the K-L grade and Cartilage Lesion Score, between the two groups (p > 0.05). Besides, the satisfaction treated by the PRP was 78.6%, with a superiority compared with HA (55.8%, p < 0.05), and no complications were noted in the whole treatment process among patients who participated.Conclusion: PRP was more effective than HA in survival and re-intervention rates, VAS, and WOMAC, although there were no significant differences in the imaging evaluation between the two groups. Furthermore, patients treated with PRP were associated with higher satisfaction compared with HA. |
| first_indexed | 2024-04-11T13:48:39Z |
| format | Article |
| id | doaj.art-a0de58890f2b47fb9a384ce6f4817253 |
| institution | Directory Open Access Journal |
| issn | 2296-4185 |
| language | English |
| last_indexed | 2024-04-11T13:48:39Z |
| publishDate | 2022-11-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Bioengineering and Biotechnology |
| spelling | doaj.art-a0de58890f2b47fb9a384ce6f48172532022-12-22T04:20:50ZengFrontiers Media S.A.Frontiers in Bioengineering and Biotechnology2296-41852022-11-011010.3389/fbioe.2022.10623711062371Assessment of the effectiveness and satisfaction of platelet-rich plasma compared with hyaluronic acid in knee osteoarthritis at minimum 7-year follow-up: A post hoc analysis of a randomized controlled trialZhengming Wang0Zhengming Wang1Rui Wang2Sicheng Xiang3Yong Gu4Ting Xu5Hengkai Jin6Xinbo Gu7Peijian Tong8Hongsheng Zhan9Hongsheng Zhan10Shuaijie Lv11Shi’s Center of Orthopedics and Traumatology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaInstitute of Traumatology and Orthopedics, Shanghai Academy of Traditional Chinese Medicine, Shanghai, ChinaZhejiang Chinese Medical University, Hangzhou, Zhejiang, ChinaZhejiang Chinese Medical University, Hangzhou, Zhejiang, ChinaZhangjiagang TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Zhangjiagang, Jiangsu, ChinaZhejiang Chinese Medical University, Hangzhou, Zhejiang, ChinaZhejiang Chinese Medical University, Hangzhou, Zhejiang, ChinaZhejiang Chinese Medical University, Hangzhou, Zhejiang, ChinaThe First Affiliated Hospital of Zhejiang Chinese Medical University, Zhejiang Provincial Hospital of Chinese Medicine, Hangzhou, Zhejiang, ChinaShi’s Center of Orthopedics and Traumatology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, ChinaInstitute of Traumatology and Orthopedics, Shanghai Academy of Traditional Chinese Medicine, Shanghai, ChinaThe First Affiliated Hospital of Zhejiang Chinese Medical University, Zhejiang Provincial Hospital of Chinese Medicine, Hangzhou, Zhejiang, ChinaBackground: Knee osteoarthritis (KOA) can be effectively treated conservatively using platelet-rich plasma (PRP) injections into the affected joints. While the short-term therapeutic clinical benefits were well documented, the mid-term results remain undetermined. To clarify its efficacy, the mid-term clinical outcomes of intra-articular injections of either PRP or hyaluronic acid (HA) in KOA were compared.Methods: One hundred patients who complied with the inclusion criteria were randomized to undergo once a week 3 weeks, intra-articular injections of either PRP or HA. Patients were evaluated before the injection, at 3, 6, and a mean of 78.9 months of follow-up. Eighty-five patients reached the final evaluation. Data on survival, re-intervention, pain, function, imaging, and satisfaction were collected and analyzed.Results: With surgery for any reason as the endpoint, the cumulative survival rate of the PRP group was 90%, while that of the HA group was 74%. There was a significant difference between the two groups in the total re-intervention rate (56.7% vs 16.2%, p < 0.05). The comparative analyses showed significant intergroup differences in the visual analog scale (VAS) and the Western Ontario and McMaster Universities Arthritis Index (WOMAC) (p < 0.01, p < 0.05, respectively) at the final follow-up. And base on the regression analyses, the type of treatment, age, and Kellgren-Lawrence (K-L) grade served as statistically an independent determinants of VAS (p < 0.001, p = 0.034, p < 0.001, respectively). Likewise, those variables independently determined WOMAC in our study. However, no difference was observed in the imaging evaluation, containing the K-L grade and Cartilage Lesion Score, between the two groups (p > 0.05). Besides, the satisfaction treated by the PRP was 78.6%, with a superiority compared with HA (55.8%, p < 0.05), and no complications were noted in the whole treatment process among patients who participated.Conclusion: PRP was more effective than HA in survival and re-intervention rates, VAS, and WOMAC, although there were no significant differences in the imaging evaluation between the two groups. Furthermore, patients treated with PRP were associated with higher satisfaction compared with HA.https://www.frontiersin.org/articles/10.3389/fbioe.2022.1062371/fullosteoarthritisplatelet-rich plasmahyaluronic acidkneeintra-articular injection |
| spellingShingle | Zhengming Wang Zhengming Wang Rui Wang Sicheng Xiang Yong Gu Ting Xu Hengkai Jin Xinbo Gu Peijian Tong Hongsheng Zhan Hongsheng Zhan Shuaijie Lv Assessment of the effectiveness and satisfaction of platelet-rich plasma compared with hyaluronic acid in knee osteoarthritis at minimum 7-year follow-up: A post hoc analysis of a randomized controlled trial Frontiers in Bioengineering and Biotechnology osteoarthritis platelet-rich plasma hyaluronic acid knee intra-articular injection |
| title | Assessment of the effectiveness and satisfaction of platelet-rich plasma compared with hyaluronic acid in knee osteoarthritis at minimum 7-year follow-up: A post hoc analysis of a randomized controlled trial |
| title_full | Assessment of the effectiveness and satisfaction of platelet-rich plasma compared with hyaluronic acid in knee osteoarthritis at minimum 7-year follow-up: A post hoc analysis of a randomized controlled trial |
| title_fullStr | Assessment of the effectiveness and satisfaction of platelet-rich plasma compared with hyaluronic acid in knee osteoarthritis at minimum 7-year follow-up: A post hoc analysis of a randomized controlled trial |
| title_full_unstemmed | Assessment of the effectiveness and satisfaction of platelet-rich plasma compared with hyaluronic acid in knee osteoarthritis at minimum 7-year follow-up: A post hoc analysis of a randomized controlled trial |
| title_short | Assessment of the effectiveness and satisfaction of platelet-rich plasma compared with hyaluronic acid in knee osteoarthritis at minimum 7-year follow-up: A post hoc analysis of a randomized controlled trial |
| title_sort | assessment of the effectiveness and satisfaction of platelet rich plasma compared with hyaluronic acid in knee osteoarthritis at minimum 7 year follow up a post hoc analysis of a randomized controlled trial |
| topic | osteoarthritis platelet-rich plasma hyaluronic acid knee intra-articular injection |
| url | https://www.frontiersin.org/articles/10.3389/fbioe.2022.1062371/full |
| work_keys_str_mv | AT zhengmingwang assessmentoftheeffectivenessandsatisfactionofplateletrichplasmacomparedwithhyaluronicacidinkneeosteoarthritisatminimum7yearfollowupaposthocanalysisofarandomizedcontrolledtrial AT zhengmingwang assessmentoftheeffectivenessandsatisfactionofplateletrichplasmacomparedwithhyaluronicacidinkneeosteoarthritisatminimum7yearfollowupaposthocanalysisofarandomizedcontrolledtrial AT ruiwang assessmentoftheeffectivenessandsatisfactionofplateletrichplasmacomparedwithhyaluronicacidinkneeosteoarthritisatminimum7yearfollowupaposthocanalysisofarandomizedcontrolledtrial AT sichengxiang assessmentoftheeffectivenessandsatisfactionofplateletrichplasmacomparedwithhyaluronicacidinkneeosteoarthritisatminimum7yearfollowupaposthocanalysisofarandomizedcontrolledtrial AT yonggu assessmentoftheeffectivenessandsatisfactionofplateletrichplasmacomparedwithhyaluronicacidinkneeosteoarthritisatminimum7yearfollowupaposthocanalysisofarandomizedcontrolledtrial AT tingxu assessmentoftheeffectivenessandsatisfactionofplateletrichplasmacomparedwithhyaluronicacidinkneeosteoarthritisatminimum7yearfollowupaposthocanalysisofarandomizedcontrolledtrial AT hengkaijin assessmentoftheeffectivenessandsatisfactionofplateletrichplasmacomparedwithhyaluronicacidinkneeosteoarthritisatminimum7yearfollowupaposthocanalysisofarandomizedcontrolledtrial AT xinbogu assessmentoftheeffectivenessandsatisfactionofplateletrichplasmacomparedwithhyaluronicacidinkneeosteoarthritisatminimum7yearfollowupaposthocanalysisofarandomizedcontrolledtrial AT peijiantong assessmentoftheeffectivenessandsatisfactionofplateletrichplasmacomparedwithhyaluronicacidinkneeosteoarthritisatminimum7yearfollowupaposthocanalysisofarandomizedcontrolledtrial AT hongshengzhan assessmentoftheeffectivenessandsatisfactionofplateletrichplasmacomparedwithhyaluronicacidinkneeosteoarthritisatminimum7yearfollowupaposthocanalysisofarandomizedcontrolledtrial AT hongshengzhan assessmentoftheeffectivenessandsatisfactionofplateletrichplasmacomparedwithhyaluronicacidinkneeosteoarthritisatminimum7yearfollowupaposthocanalysisofarandomizedcontrolledtrial AT shuaijielv assessmentoftheeffectivenessandsatisfactionofplateletrichplasmacomparedwithhyaluronicacidinkneeosteoarthritisatminimum7yearfollowupaposthocanalysisofarandomizedcontrolledtrial |